ArticleEnvironmental science and pollution research international2022
Dose-response relationships between urinary cobalt concentrations and obesity, insulin resistance, and metabolic-related disorders in the general population.
Article in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- The association between modified cardiometabolic index and cardiovascular disease risk in adults with early cardiovascular-kidney-metabolic syndrome: a prospective cohort study.BMC cardiovascular disorders · 2026Article
- Article
- Exploring the Impact of Urinary Metal Exposure on Blood Lipid Profiles in Chinese Adults: Mediating Roles of Health-Related Indicators.Journal of the American Heart Association · 2025Article
- Effects of Various Heavy Metal Exposures on Insulin Resistance in Non-diabetic Populations: Interpretability Analysis from Machine Learning Modeling Perspective.Biological trace element research · 2024Article
- Maternal cobalt concentration and risk of spontaneous preterm birth: the role of fasting blood glucose and lipid profiles.Frontiers in nutrition · 2024Article
- Heavy metals contamination of seafood from the crude oil-impacted Niger Delta Region of Nigeria: A systematic review and meta-analysis.Toxicology reports · 2023Review
- Interactive Effects of Obesity and Hypertension on Patterns of Hair Essential Trace Element and Mineral Content in Adult Women.Biological trace element research · 2023Article
- Vanadium, cobalt, zinc, and rubidium are associated with markers of inflammation and oxidative stress in a Greek population with obesity.Frontiers in endocrinology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Excessive cobalt exposure has been shown to induce various adverse health effects in animal and human toxicity studies. However, the relationships between cobalt exposure and obesity, insulin resistance, and metabolic-related disorders are rarely studied in epidemiological studies. This study aimed to explore the dose-response relationships between urinary cobalt concentrations and obesity, insulin resistance, and metabolic-related disorders. Adult participants (≥20 years) from the 2005 to 2018 National Health and Nutrition Examination Survey were included. Restricted cubic splines and the log-binomial regression were adopted. Multivariate adjusted prevalence ratios (95% confidence intervals) comparing extreme quartiles of urinary cobalt concentrations were 1.43 (1.29-1.57) for obesity, 1.43 (1.10-1.86) for insulin resistance, 1.21 (1.09-1.34) for metabolic syndrome, 1.16 (1.10-1.23) for elevated waist circumference, 1.20 (1.09-1.33) for elevated triglycerides, 1.14 (1.01-1.29) for reduced high-density lipoprotein cholesterol (HDL-C), 1.06 (0.98-1.15) for elevated blood pressure, and 0.91 (0.79-1.06) for elevated fasting glucose, respectively. Results from the restricted cubic splines showed that an initial steep increase in risk was followed by a weaker increase in risk or a platform beyond 1.0 µg/L for obesity (prevalence ratio (95% confidence interval): 1.41 (1.29-1.55)), insulin resistance (1.33 (1.07-1.65)), metabolic syndrome (1.18 (1.11-1.31)), elevated waist circumference (1.18 (1.11-1.25)), elevated triglycerides (1.21 (1.11-1.33)), and reduced HDL-C (1.15 (1.01-1.30)), respectively. In conclusion, the prevalence of obesity, insulin resistance, metabolic syndrome, elevated waist circumference, elevated triglycerides, and reduced HDL-C progressively increased with increasing urinary cobalt concentrations. The above associations are non-linear and there is not a "safe threshold" below which there are no toxic effects of cobalt.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.